Citation: K. Brinkman et al., THERAPEUTIC CONCENTRATIONS OF INDINAVIR IN CEREBROSPINAL-FLUID OF HIV-1-INFECTED PATIENTS, AIDS, 12(5), 1998, pp. 537-537
Authors:
BURGER DM
HUGEN PWH
KROON FP
GROENEVELD P
BRINKMAN K
FOUDRAINE NA
SPRENGER H
KOOPMANS PP
HEKSTER YA
Citation: Dm. Burger et al., PHARMACOKINETIC INTERACTION BETWEEN THE PROTON PUMP INHIBITOR OMEPRAZOLE AND THE HIV PROTEASE INHIBITOR INDINAVIR, AIDS, 12(15), 1998, pp. 2080-2082
Authors:
BRINKMAN K
TERHOFSTEDE HJM
BURGER DM
SMEITINKT JAM
KOOPMANS PP
Citation: K. Brinkman et al., ADVERSE-EFFECTS OF REVERSE-TRANSCRIPTASE INHIBITORS - MITOCHONDRIAL TOXICITY AS COMMON PATHWAY, AIDS, 12(14), 1998, pp. 1735-1744
Authors:
BURGER DM
DEGRAAFF M
WUIS EW
KOOPMANS PP
HEKSTER YA
Citation: Dm. Burger et al., DETERMINATION OF INDINAVIR, AN HIV-PROTEASE INHIBITOR, IN HUMAN PLASMA BY REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Journal of chromatography B. Biomedical sciences and applications, 703(1-2), 1997, pp. 235-241
Citation: Rmw. Hoetelmans et al., PENETRATION OF 3'-AMINO-3'-DEOXYTHYMIDINE, A CYTOTOXIC METABOLITE OF ZIDOVUDINE, INTO THE CEREBROSPINAL-FLUID OF HIV-1-INFECTED PATIENTS, Journal of acquired immune deficiency syndromes and human retrovirology, 15(2), 1997, pp. 131-136
Citation: Rmw. Hoetelmans et al., CLINICAL-PHARMACOLOGY OF HIV PROTEASE INHIBITORS - FOCUS ON SAQUINAVIR, INDINAVIR, AND RITONAVIR, Pharmacy world & science, 19(4), 1997, pp. 159-175
Citation: Dm. Burger et al., LABORATORY TECHNIQUES IN DRUG DEVELOPMENT .5. EVALUATION OF 2 IMMUNOASSAYS FOR THE DETERMINATION OF ZIDOVUDINE IN BIOLOGICAL MATRICES, Journal of drug development and clinical practice, 7(4), 1996, pp. 313-318
Citation: Lmw. Hoetelmans et al., PHARMACOKINETIC INDIVIDUALIZATION OF ZIDOVUDINE THERAPY - CURRENT STATE OF PHARMACOKINETIC-PHARMACODYNAMIC RELATIONSHIPS, Clinical pharmacokinetics, 30(4), 1996, pp. 314-327
Citation: Rmw. Hoetelmans et al., PENETRATION OF 3'-AMINO 3'-DEOXYTHYMIDINE, A CYTOTOXIC METABOLITE OF ZIDOVUDINE, INTO THE CEREBROSPINAL-FLUID OF HIV-1-INFECTED PATIENTS, AIDS, 10, 1996, pp. 23-23
Citation: Dm. Burger et al., STUDY ON DIDANOSINE CONCENTRATIONS IN CEREBROSPINAL-FLUID - IMPLICATIONS FOR THE TREATMENT AND PREVENTION OF AIDS, Pharmacy world & science, 17(6), 1995, pp. 218-221
Citation: Dm. Burger, BIOANALYSIS AND CLINICAL PHARMACOKINETICS OF ANTIRETROVIRAL AGENTS INHIV-INFECTED INDIVIDUALS, Pharmacy world & science, 17(6), 1995, pp. 222-224
Citation: Dm. Burger et al., CONCISE OVERVIEW OF THE CLINICAL PHARMACOKINETICS OF DIDEOXYNUCLEOSIDE ANTIRETROVIRAL AGENTS, Pharmacy world & science, 17(2), 1995, pp. 25-30
Citation: Dm. Burger et al., LIMITED SAMPLING MODELS FOR THE ANTIRETROVIRAL AGENT DIDANOSINE, European journal of pharmaceutical sciences, 3(1), 1995, pp. 7-13
Authors:
BURGER DM
MEENHORST PL
KOKS CHW
BEIJNEN JH
Citation: Dm. Burger et al., PHARMACOKINETICS OF ZIDOVUDINE AND ACETAMINOPHEN IN A PATIENT ON CHRONIC ACETAMINOPHEN THERAPY, The Annals of pharmacotherapy, 28(3), 1994, pp. 327-330
Citation: Dm. Burger et al., SHORT-TERM, COMBINED USE OF PARACETAMOL AND ZIDOVUDINE DOES NOT ALTERTHE PHARMACOKINETICS OF EITHER DRUG, Netherlands journal of medicine, 44(5), 1994, pp. 161-165
Authors:
BURGER DM
MEENHORST PL
TENNAPEL CHH
MULDER JW
NEEF C
KOKS CHW
BULT A
BEIJNEN JH
Citation: Dm. Burger et al., PHARMACOKINETIC VARIABILITY OF ZIDOVUDINE IN HIV-INFECTED INDIVIDUALS- SUBGROUP ANALYSIS AND DRUG-INTERACTIONS, AIDS, 8(12), 1994, pp. 1683-1689
Authors:
BURGER DM
MEENHORST PL
MULDER JW
KRAAIJEVELD CL
KOKS CHW
BULT A
BEIJNEN JH
Citation: Dm. Burger et al., THERAPEUTIC DRUG-MONITORING OF PHENYTOIN IN PATIENTS WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME, Therapeutic drug monitoring, 16(6), 1994, pp. 616-620
Authors:
BURGER DM
MEENHORST PL
MULDER JW
KOKS CHW
BULT A
BEIJNEN JH
Citation: Dm. Burger et al., PHARMACOKINETICS OF ZIDOVUDINE AND METABOLITES IN A PATIENT WITH HIV-ASSOCIATED NEPHROPATHY AND SEVERE RENAL IMPAIRMENT, Drug investigation, 7(5), 1994, pp. 282-287
Authors:
BURGER DM
ROSING H
TENNAPEL CHH
DUYTS T
MEENHORST PL
MULDER JW
KOKS CHW
BULT A
BEIJNEN JH
Citation: Dm. Burger et al., APPLICATION OF A RADIOIMMUNOASSAY FOR DETERMINATION OF LEVELS OF ZALCITABINE (DDC) IN HUMAN PLASMA, URINE, AND CEREBROSPINAL-FLUID, Antimicrobial agents and chemotherapy, 38(12), 1994, pp. 2763-2767
Authors:
BURGER DM
VANDIJK EA
VANGIJN R
BEIJNEN JH
Citation: Dm. Burger et al., EFFECT OF HEAT-TREATMENT OF POTENTIALLY INFECTED BLOOD-SAMPLES ON THERAPEUTIC DRUG-MONITORING OF SELECTED DRUGS, The Annals of pharmacotherapy, 27(7-8), 1993, pp. 887-888
Citation: Wj. Keijer et al., OCULAR COMPLICATIONS OF THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME - FOCUS ON THE TREATMENT OF CYTOMEGALOVIRUS RETINITIS WITH GANCICLOVIR AND FOSCARNET, Pharmacy world & science, 15(2), 1993, pp. 56-67
Authors:
BEKERS O
BEIJNEN JH
TANK MJTK
BURGER DM
MEENHORST PL
LOMBARTS AJPF
UNDERBERG WJM
Citation: O. Bekers et al., 2',3'-DIDEOXYINOSINE (DDI) - ITS CHEMICAL-STABILITY AND CYCLODEXTRIN COMPLEXATION IN AQUEOUS-MEDIA, Journal of pharmaceutical and biomedical analysis, 11(6), 1993, pp. 489-493
Authors:
BURGER DM
ROSING H
KOOPMAN FJ
MEENHORST PL
MULDER JW
BULT A
BEIJNEN JH
Citation: Dm. Burger et al., DETERMINATION OF 3'-AMINO-3'-DEOXYTHYMIDINE, A CYTOTOXIC METABOLITE OF 3'-AZIDO-3'-DEOXYTHYMIDINE, IN HUMAN PLASMA BY ION-PAIR HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY, Journal of chromatography. Biomedical applications, 622(2), 1993, pp. 235-242